New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Rigel Pharmaceuticals, Inc (NASDAQ:RIGL), Globalstar, Inc (OTCMKTS:GSAT), DryShips Inc (NASDAQ:DRYS), Dynavax Technologies Corporation (NASDAQ:DVAX)
Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) showed a volume of 1.24 million shares by the end of last trade whereas the average volume of the stock remained 1.02 million shares. The stock opened the session at $2.51 but then moved to $2.59. At that price, the stock showed a positive performance of 4.86%. Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. As of December 31, 2011, product development programs included fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis (RA) with its partner AstraZeneca (AZ); R343, an inhaled SYK inhibitor for asthma and R333,
Will RIGL Continue To Move Higher? Find Out Here
Globalstar, Inc (OTCMKTS:GSAT) opened the session at $1.95 and closed the session at $1.86. The stock showed a negative performance of -2.62% in previous trading session. Traded with volume of 1.07 million shares in the prior session and the average volume of the stock remained 3.92 million shares. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation. As of March 2, 2012,
Has GSAT Found The Bottom And Ready To Gain Momentum? Find Out Here
DryShips Inc (NASDAQ:DRYS) opened the session at $3.72 and closed the session at $3.93. The stock showed a positive performance of 6.50% in previous trading session. Traded with volume of 13.44 million shares in the prior session and the average volume of the stock remained 9.41 million shares. The beta of the stock remained 2.97. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units. As of December 31, 2011, it owned and operated two fifth generation ultra-deepwater, semi-submersible offshore drilling rigs, the Leiv Eiriksson and the Eirik Raude, and four sixth generation,
Why Should Investors Buy DRYS After The Recent Gain? Just Go Here and Find Out
Dynavax Technologies Corporation (NASDAQ:DVAX) the stock advanced 9.34% and finished the session at $1.99. Traded with volume of 7.33 million shares in the prior session and the average volume of the stock 5.78 million shares. The beta of the stock remained 1.85. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines. The Company’s pipeline of product candidates includes HEPLISAV, its autoimmune program partnered with GlaxoSmithKline (GSK),
Will DVAX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)